Minerva Neurosciences, Inc. — Director's Dealing 2018

Oct 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2018-10-01

Reporting Person: Reilly Joseph H. (SVP & Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-01	Common Stock	M	15000	$4.71	Acquired	29177	Direct
2018-10-01	Common Stock	M	10000	$5.19	Acquired	39177	Direct
2018-10-01	Common Stock	S	23300	$12.02	Disposed	15877	Direct
2018-10-01	Common Stock	S	1700	$12.62	Disposed	14177	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-01	Employee Stock Option (Right to Buy)	$4.71	M	15000	Disposed	2025-12-03	Common Stock (15000)	Direct
2018-10-01	Employee Stock Option (Right to Buy)	$5.19	M	10000	Disposed	2025-04-13	Common Stock (10000)	Direct

Footnotes

F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2016.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.60 to $12.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.60 to $12.69, inclusive.

F4: This option vested 25% on December 4, 2016 and then in quarterly installments over 3 years thereafter.

F5: This option vested 25% on April 14, 2016 and then in quarterly installments over 3 years thereafter.